You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GLUE Sale Disclosure
Janku Filip · SEC Form 4 · Filed Jun 25, 2026
Sale
Calculated transaction value
$642.68K
Janku Filip Chief Medical Officer
GLUE
Transaction date
Jun 24, 2026
Public filing date
Jun 25, 2026
Filing lag
Filed 1 day later
GLUE daily price context
Close on/before transaction
$20.85
Jun 24, 2026
First close after public filing
$22.29
Jun 26, 2026
30-day return after filing
+1.21%
Through Jul 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 30,000 shares @ $21.42
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-282740
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$1.15M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jun 24, 2026 | $226.8K |
| Monte Rosa Therapeutics, Inc. GLUE Current | Sale | Jun 24, 2026 | $642.68K |
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jun 24, 2026 | $0 |
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jun 23, 2026 | $45.36K |
| Monte Rosa Therapeutics, Inc. GLUE | Sale | Jun 23, 2026 | $239.52K |
| Monte Rosa Therapeutics, Inc. GLUE | Exercise | Jun 23, 2026 | $0 |